Technology to watch in 2018: boosting cancer vaccines
In the field of cancer immunogenomics, researchers want to know which of the mutated proteins encoded by the cancer genome are capable of eliciting an immune response in a given individual. Such proteins, called neo-antigens, could be utilized to develop personalized cancer vaccines or indicate other treatments.
One exciting technology that could be used to study these neo-antigens is CyTOF®, a so-called mass-cytometry method for identifying cells that express specific proteins.
Mardis, E. "Technology to watch in 2018: boosting cancer vaccines" Nature (2018): 532